What is ClearPoint Neuro?
ClearPoint Neuro Inc. is a prominent medical device company dedicated to the development and commercialization of advanced platforms for minimally invasive surgical procedures within the brain. The company's core offerings include sophisticated navigation and delivery systems that facilitate precise targeting and real-time MRI guidance during complex neurosurgical interventions. These technologies are instrumental in a variety of therapeutic applications, such as deep brain stimulation, laser ablation, biopsy procedures, and targeted drug delivery for neurological conditions. ClearPoint Neuro's solutions are engineered to elevate surgical accuracy, improve patient outcomes, and broaden treatment possibilities for challenging brain disorders, serving neurosurgeons and healthcare institutions that require cutting-edge tools for image-guided neurosurgery.
How much funding has ClearPoint Neuro raised?
ClearPoint Neuro has raised a total of $180.5M across 6 funding rounds:
Debt
$1.3M
Debt
$350K
Debt
$7.5M
Stock Offering
$43.4M
Other Financing Round
$110M
Private Equity
$17.9M
Debt (2011): $1.3M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Debt (2020): $7.5M supported by Petrichor Healthcare Capital Management
Stock Issuance/Offering (2021): $43.4M, investors not publicly disclosed
Other Financing Round (2025): $110M backed by Oberland Capital
Private Equity (2026): $17.9M, investors not publicly disclosed
Key Investors in ClearPoint Neuro
Oberland Capital
Oberland Capital is a private investment firm focused on funding innovation in the global healthcare industry, managing approximately $3 billion in assets. The firm specializes in flexible investment structures tailored to meet the specific needs of its partners, offering a range of financing solutions including monetization of royalty streams and project-based financing.
What's next for ClearPoint Neuro?
The recent major strategic investment positions ClearPoint Neuro for accelerated expansion and further innovation in the neurosurgical technology market. This capital infusion is expected to fuel the enhancement of existing product lines and the development of next-generation devices, potentially expanding their reach into new therapeutic areas or geographical markets. The company's focus on precision and minimally invasive techniques aligns with the growing demand for safer and more effective surgical interventions. Future strategic initiatives will likely involve strengthening partnerships with key medical institutions, advancing clinical research, and navigating regulatory pathways to broaden the application of their technology, thereby solidifying their leadership in image-guided neurosurgery.
See full ClearPoint Neuro company page
